OLMA - Company ID 0001750284
The table below shows Olema Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$45.99M | -$43.98M | -$23.50M | -$20.39M | -$17.90M | -$11.08M |
| Capital expenditure | - | - | $153.00K | - | $30.00K | $420.00K |
| Investing cash flow | $4.53M | -$45.08M | -$20.14M | $37.39M | $25.57M | -$279.58M |
| Dividends paid | - | - | - | - |
Olema Pharmaceuticals, Inc. reported operating cash flow of -$146.72M for fiscal year 2025. That is down 40.6% from -$104.35M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$3.08M (FY 2019) to -$146.72M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $45.70M | $222.00K | $8.82M | $220.00K | $33.00K | - |